NASDAQ:ALT

Altimmune Earning Date

USA |NASDAQ |USD

ALT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.39 $-0.60 $-0.54
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $60.00K $137.62K $2.94M

Altimmune's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

ALT Earnings Date & History Chart

ALT Earnings & Revenue Forecast

ALT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.43 $-0.57 $-0.21
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.77 $-2.08 $-1.42
Dec 2022 6 $-1.79 $-2.56 $-0.70

ALT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.43 $-0.43 $-0.51
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.77 $-1.74 $-1.88
Dec 2022 0 / 0 $-1.79 $-1.80 $-2.07

ALT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $60.00K $0.00 $140.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $1.13M $1.00M $1.30M
Dec 2022 6 $3.66M $0.00 $20.00M

ALT Earnings Date & Revenue History

ALT Earnings History

|
Show More
Show More

ALT Revenue History

|
Show More
Show More

Altimmune Next Earnings Date & Report

ALT Next Earnings Date & Report Preview: Sep 2021 (FQ)

ALT's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Altimmune's next quarterly earnings is $-0.39, with a low EPS estimation of $-0.52, and a high estimation of $-0.23.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.39, the last 2 month trend is $-0.39, and the 3 month trend is $-0.48.

Based on 6 analysts, the average revenue estimation is $60.00K, with a low revenue estimation of $0.00, and a high estimation of $140.00K.

Altimmune Previous Earnings Dates & Reports

ALT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Altimmune's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

ALT's earnings per share (EPS) was $-0.60, missing the consensus analysts forecast of $-0.51 by -18.81%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 57.89%, and higher than the same period a year before (Jun 2020) by -36.17%.

Revenues were $137.62K, worse than the forecast of $1.89M by -92.72%, down by -83.57% from the previous quarter , and down by -80.93% from the same period last year.

The company reported a net income of $-24.83M.

Free cash flow for the quarter was $-26.70M , compared to $-23.84M last quarter and $-7.25M a year before.

ALT ended the quarter with $1.65M in total debt, a decrease of -5.08% compared to the previous quarter, and a decrease of -26.61% compared to the same quarter a year before.

ALT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Altimmune's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

ALT's earnings per share (EPS) was $-1.91, beating the consensus analysts forecast of $-2.59 by -26.25% , and lower than the previous year's EPS (Dec 2019) by 25.66%.

Revenues were $8.19M, better than the forecast of $7.71M by 6.16%, and up by 41.09% from previous year's revenue.

The company reported a net income of $-49.04M.

Altimmune reported a free cash flow of $-34.78M for its fiscal year, compared to $-9.63M a year ago.

The company ended the fiscal year with $1.82M in total debt, an increase of 4.63% compared to the previous year.